Form D — Nanopath Inc
0001940981-26-000003 · filed Nov 13, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $36,760,740
- Reported amount sold
- $29,891,706
- Minimum investment
- $0
- Investors
- 21
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Nanopath Inc
- CIK
- 1940981
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 750 MAIN STREET
CAMBRIDGE, Massachusetts 02139 - Phone
- 617-249-4542
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Amogha Tadimety · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Alison Burklund · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Jeff Crowe · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Aaron Sandoski · DirectorCambridge, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗